Henry A. Palfrey

Postdoctoral Research Associate / HSIE fellow

University of Arkansas for Medical Sciences

postdoc

3 h-index 10 pubs 396 cited

Research Areas

Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Dialysis and Renal Disease Management Research Commercialization and Startup Development Radiation Therapy and Dosimetry Metabolism and Genetic Disorders

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Henry A. Palfrey is a postdoctoral fellow at the University of Arkansas for Medical Sciences, where his research focuses on the role of eicosanoids in kidney and cardiovascular function. His work specifically investigates radiation-induced kidney injury and potential pharmacotherapeutic interventions. Palfrey also contributes to a startup team developing a novel medical device, stemming from a research commercialization fellowship, with the goal of market launch.

His publication record includes studies on the effects of DPP-4 inhibitors and sitagliptin on hypercholesterolemia and cardiac events in rats. He has also published research on dual inhibitors of TGFβR1/MAP4K4, examining their effects on renal fibrosis and injury in mouse models. Palfrey's work also includes investigations into the impact of low kidney mass on radiation-induced renal hemodynamic dysfunction in mice.

Palfrey has a h-index of 3, with 10 publications and 396 citations. Key collaborators include John D. Imig and Samaneh Goorani, both from the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications.

Metrics

  • h-index: 3
  • Publications: 10
  • Citations: 396

Selected Publications

  • Transforming growth factor β receptor 1 and mitogen-activated protein 4 kinase 4 dual inhibitor, TK-850, reduces renal fibrosis in unilateral ureteral–obstructed mice (2025) DOI
  • 591 Low kidney mass contributes to enhanced fractionated irradiation-induced renal hemodynamic dysfunction in mice (2025) DOI
  • Attenuation of renal injury by administration of TK-850, a dual inhibitor of TGFβR1/MAP4K4 (2024) DOI
  • 557 Dual TGFβR1/MAP4K4 inhibitor reduces kidney injury in a mouse model of renal fibrosis. (2024) DOI

Collaborators

Researchers in the database who share publications

John D. Imig University of Arkansas for Medical Sciences 4 shared publications Samaneh Goorani University of Arkansas for Medical Sciences 4 shared publications Abdul H. Khan University of Arkansas for Medical Sciences 2 shared publications Abhishek Mishra University of Arkansas for Medical Sciences 2 shared publications Rupak Pathak University of Arkansas for Medical Sciences 1 shared publication Mohani Abdul University of Arkansas for Medical Sciences 1 shared publication

Similar Researchers

Based on overlapping research topics

John D. Imig University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Dialysis and Renal Disease Management
Good match 4 shared topics
Layth Al-Hindi University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Dialysis and Renal Disease Management
Good match 3 shared topics
R. Scicali University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Metabolism and Genetic Disorders
Good match 3 shared topics
Otis M. Davis University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Dialysis and Renal Disease Management
Good match 3 shared topics
Emma Matherne University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Metabolism and Genetic Disorders
Good match 3 shared topics
Emily D. Sprick University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors Pharmacological Effects and Toxicity Studies Radiation Therapy and Dosimetry
Good match 3 shared topics